Cardiotoxic potential and CNS effects of first-generation antihistamines

Trends Pharmacol Sci. 2000 Feb;21(2):52-6. doi: 10.1016/s0165-6147(99)01437-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Central Nervous System / drug effects*
  • Central Nervous System / physiology
  • Diphenhydramine / adverse effects
  • Diphenhydramine / pharmacology
  • Electrophysiology
  • Heart / drug effects*
  • Heart / physiology
  • Histamine H1 Antagonists / adverse effects*
  • Histamine H1 Antagonists / chemistry
  • Histamine H1 Antagonists / pharmacology
  • Humans
  • Hydroxyzine / adverse effects
  • Hydroxyzine / pharmacology
  • Potassium Channel Blockers
  • Potassium Channels / metabolism
  • Receptors, Histamine H1 / metabolism
  • Structure-Activity Relationship

Substances

  • Histamine H1 Antagonists
  • Potassium Channel Blockers
  • Potassium Channels
  • Receptors, Histamine H1
  • Hydroxyzine
  • Diphenhydramine

Grants and funding